Loading...

Solventum Corporation

SOLVNYSE
HealthcareMedical - Care Facilities
$74.84
$-0.53(-0.70%)

Solventum Corporation (SOLV) Stock Overview

Explore Solventum Corporation’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
0.70%
0.70%
Profit Growth
$2.18
64.41%
EPS Growth
$2.18
64.44%
Operating Margin
9.71%
38.77%
ROE
12.31%
64.41%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$55.00
Average$72.50
High$82.00

Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

CEO

Mr. Bryan C. Hanson

Employees

22,000

Headquarters

3M Center, Maplewood, MN

Founded

2024

Frequently Asked Questions